Am Heart J

1. SMOLDEREN KG, Romain G, Cleman J, Scierka L, et al
   Variability in guideline-directed medical therapy across sites and operators and long-term mortality and amputation outcomes risk in patients undergoing peripheral vascular interventions.
   Am Heart J. 2024;270:75-85.
   

   >> Share

   
   
2. ZHANG L, Wang W, Huo X, He G, et al
   Predicting the risk of 1-year mortality among patients hospitalized for acute heart failure in China.
   Am Heart J. 2024 Mar 13:S0002-8703(24)00066-8. doi: 10.1016/j.ahj.2024.
   

   >> Share

   
   
3. MANJA V, Sandhu ATS, Asch S, Frayne S, et al
   Healthcare utilization and left ventricular ejection fraction distribution in methamphetamine use associated heart failure hospitalizations.
   Am Heart J. 2024;270:156-160.
   

   >> Share

   
   

   
   Cardiovasc Res

4. KESIDOU D, Beqqali A, Baker AH
   The dual effects of miR-222 in cardiac hypertrophy: bridging pathological and physiological paradigms.
   Cardiovasc Res. 2024;120:217-219.
   

   >> Share

   
   

   
   Circ Arrhythm Electrophysiol

5. RAMDAT MISIER NL, Moore JP, Nguyen HH, Lloyd MS, et al
   Long-Term Outcomes of Cardiac Resynchronization Therapy in Patients With Repaired Tetralogy of Fallot: A Multicenter Study.
   Circ Arrhythm Electrophysiol. 2024;17:e012363.
   

   >> Share

   
   

   
   Circ Cardiovasc Imaging

6. AKASHI J, Iwataki M, Nabeshima Y, Onoue T, et al
   Potential Effects of Mild Atrial Secondary Mitral Regurgitation in Patients With Isolated Atrial Fibrillation.
   Circ Cardiovasc Imaging. 2024 Feb 28:e016239.
   

   >> Share

   
   

   
   Circ Cardiovasc Interv

7. SCARSINI R, Kotronias RA, Della Mora F, Portolan L, et al
   Angiography-Derived Index of Microcirculatory Resistance to Define the Risk of Early Discharge in STEMI.
   Circ Cardiovasc Interv. 2024 Feb 20:e013556.
   

   >> Share

   
   

   
   Circ Cardiovasc Qual Outcomes

8. TAJEU GS, Ruiz-Negron N, Moran AE, Zhang Z, et al
   Cost of Cardiovascular Disease Event and Cardiovascular Disease Treatment-Related Complication Hospitalizations in the United States.
   Circ Cardiovasc Qual Outcomes. 2024 Feb 8:e009999.
   

   >> Share

   
   

   
   Circ Genom Precis Med

9. JOO J, Shearer JJ, Wolska A, Remaley AT, et al
   Incremental Value of a Metabolic Risk Score for Heart Failure Mortality: A Population-Based Study.
   Circ Genom Precis Med. 2024 Mar 22:e004312. doi: 10.1161/CIRCGEN.123.004312.
   

   >> Share

   
   

   
   Circ Heart Fail

10. CHEN QY, Jiang YN, Guan X, Ren FF, et al
    Aerobic Exercise Attenuates Pressure Overload-Induced Myocardial Remodeling and Myocardial Inflammation via Upregulating miR-574-3p in Mice.
    Circ Heart Fail. 2024;17:e010569.
    

    >> Share

    
    
11. OCHOA JP, Lalaguna L, Mirelis JG, Dominguez F, et al
    Biallelic Loss of Function Variants in Myocardial Zonula Adherens Protein Gene (MYZAP) Cause a Severe Recessive Form of Dilated Cardiomyopathy.
    Circ Heart Fail. 2024;17:e011226.
    

    >> Share

    
    
12. L'HOYES W, Rosseel T, Jacobs B, Van Edom C, et al
    Blood Speckle Imaging in Critical Care: A New Tool in Mechanical Circulatory Support Management.
    Circ Heart Fail. 2024 Feb 8:e010697. doi: 10.1161/CIRCHEARTFAILURE.123.010697.
    

    >> Share

    
    
13. DUNN KE
    Why Ancestral Diversity in Genetic Testing Matters: Lessons Learned From Hypertrophic Cardiomyopathy.
    Circ Heart Fail. 2024;17:e011484.
    

    >> Share

    
    
14. EARLE NJ, Winbo A, Crawford J, Wheeler M, et al
    Genetic Testing Yield and Clinical Characteristics of Hypertrophic Cardiomyopathy in Understudied Ethnic Groups: Insights From a New Zealand National Registry.
    Circ Heart Fail. 2024;17:e010970.
    

    >> Share

    
    
15. DEL FRANCO A, Palinkas ED, Bellagamba CCA, Biagioni G, et al
    Long-Term Effects of Mavacamten on Electromechanical Dispersion and Deformation in Obstructive Hypertrophic Cardiomyopathy.
    Circ Heart Fail. 2024;17:e011188.
    

    >> Share

    
    
16. RUTZ T, Aubert JD, Beghetti M, Eeckhout E, et al
    Atrial Septal Defect, Pulmonary Arterial Hypertension, and Diastolic Left Heart Failure: When 3 Players Come into the Game.
    Circ Heart Fail. 2024 Mar 21:e010545. doi: 10.1161/CIRCHEARTFAILURE.123.010545.
    

    >> Share

    
    

    
    Circulation

17. JESSUP M
    A Century of Heart Failure With Reduced Ejection Fraction: Mostly Drought, Followed by Rapid Progress.
    Circulation. 2024;149:899-901.
    

    >> Share

    
    

    
    Eur Heart J

18. MURARU D, Badano LP, Hahn RT, Lang RM, et al
    Atrial secondary tricuspid regurgitation: pathophysiology, definition, diagnosis, and treatment.
    Eur Heart J. 2024 Mar 5:ehae088. doi: 10.1093.
    

    >> Share

    
    

    
    Eur J Heart Fail

19. PANICHELLA G, Tomasoni D, Aimo A
    Dissecting the heart failure phenotype through phenomics.
    Eur J Heart Fail. 2024 Mar 19. doi: 10.1002/ejhf.3204.
    

    >> Share

    
    
20. VANHENTENRIJK S, Tang WHW
    Renal perturbations with sodium-glucose cotransporter 2 inhibitor in heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2024 Mar 19. doi: 10.1002/ejhf.3205.
    

    >> Share

    
    
21. DAVIS JA, Booth D, McEwan P, Solomon SD, et al
    Cost-effectiveness of dapagliflozin for patients with heart failure across the spectrum of ejection fraction: A pooled analysis of DAPA-HF and DELIVER data.
    Eur J Heart Fail. 2024 Mar 20. doi: 10.1002/ejhf.3197.
    

    >> Share

    
    
22. SAVARESE G, Lindberg F, Christodorescu RM, Ferrini M, et al
    Physician perceptions, attitudes, and strategies towards implementing guideline-directed medical therapy in heart failure with reduced ejection fraction. A survey of the Heart Failure Association of the ESC and the ESC Council for Cardiology Practice.
    Eur J Heart Fail. 2024 Mar 22. doi: 10.1002/ejhf.3214.
    

    >> Share

    
    

    
    Int J Cardiol

23. CHAO-CHEN L
    Letter to the Editor: "Changes in walking speed 6 months after discharge may be more sensitive to subsequent prognosis than handgrip strength in patients hospitalized for heart failure".
    Int J Cardiol. 2024 Mar 13:131958. doi: 10.1016/j.ijcard.2024.131958.
    

    >> Share

    
    
24. HUA L, Zhang R, Chen R, Shao W, et al
    A nomogram for predicting the risk of heart failure with preserved ejection fraction.
    Int J Cardiol. 2024 Mar 18:131973. doi: 10.1016/j.ijcard.2024.131973.
    

    >> Share

    
    
25. KARAKITSOS P, Mylonas KS
    Raw data were not disclosed in 95% of PubMed-indexed heart failure meta-analyses in 2021: A systematic analysis of transparency.
    Int J Cardiol. 2024 Mar 19:131987. doi: 10.1016/j.ijcard.2024.131987.
    

    >> Share

    
    
26. CARIGI S, Gentile P, Gori M, Tinti D, et al
    Clinical characteristics, treatment, trajectories and outcome of patients with dilated cardiomyopathy in a national heart failure registry.
    Int J Cardiol. 2024 Mar 19:131986. doi: 10.1016/j.ijcard.2024.131986.
    

    >> Share

    
    

    
    J Am Coll Cardiol

27. ATALLAH B, Ghalib HH
    Pooling the NT-proBNP Benefits of ARNI: Fret the Index Hospitalization No More.
    J Am Coll Cardiol. 2024;83:1133-1135.
    

    >> Share

    
    
28. MORROW DA, Velazquez EJ, Desai AS, DeVore AD, et al
    Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart Failure.
    J Am Coll Cardiol. 2024;83:1123-1132.
    

    >> Share

    
    

    
    J Card Fail

29. WONG KE, Verma AK
    Rates of Reproductive Counseling and Contraception Use in Patients with Heart Failure at a Tertiary Care Center.
    J Card Fail. 2024 Mar 19:S1071-9164(24)00089.
    

    >> Share

    
    
30. CROSS SH, Dickert NW, Morris AA, Taj J, et al
    Racial Differences in Palliative Care Use in Heart Failure Decedents.
    J Card Fail. 2024 Mar 14:S1071-9164(24)00081.
    

    >> Share

    
    
31. GORODESKI EZ, Goyal P
    Cognitive Impairment Is Our Job Too.
    J Card Fail. 2024;30:423-424.
    

    >> Share

    
    
32. LYLE MA, Belkin MN
    The Veterans Affairs' Dashboard Confessional: Vindication of the VA HF Dashboard.
    J Card Fail. 2024;30:460-461.
    

    >> Share

    
    
33. AURORA L, Wanderley MRB Jr
    Signaling Pathways in Hypertrophic Cardiomyopathy: Will Proteomic Profiling Guide the Future?
    J Card Fail. 2024;30:473-475.
    

    >> Share

    
    
34. MILLIGAN C, Daly KP
    ABO-Incompatible Heart Transplantation: Where Science, Society, and Policy Collide.
    J Card Fail. 2024;30:486-487.
    

    >> Share

    
    
35. LEE C, Liang LW, Hasegawa K, Maurer MS, et al
    Signaling Pathways Associated With Prior Cardiovascular Events in Hypertrophic Cardiomyopathy.
    J Card Fail. 2024;30:462-472.
    

    >> Share

    
    
36. AMDANI S, Deshpande SR, Liu W, Urschel S, et al
    Impact of the Pediatric ABO Policy Change on Listings, Transplants, and Outcomes for Children Younger Than 2 Years Listed for Heart Transplantation in the United States.
    J Card Fail. 2024;30:476-485.
    

    >> Share

    
    

    
    PLoS One

37. NASCIMENTO PMC, Rodrigues Junior LF, Felix Mediano MF, Goncalves da Silva V, et al
    Prevalence and impact of sarcopenia in individuals with heart failure with reduced ejection fraction (the SARC-HF study): A prospective observational study protocol.
    PLoS One. 2024;19:e0300918.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share